~~<i id='0D5121E22D'><strike id='0D5121E22D'><tt id='0D5121E22D'><pre id='0D5121E22D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：Wikipedia 2025-09-03 09:36:52 - browse：62

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： STAT Virtual Event: How to Increase Diversity in Clinical Trials

leisure time

hotspot

leisure time

Wikipedia

hotspot

explore

AlexHogan/STATYou’rereadingthewebeditionofD.C.Diagnosis. Signuphere toreceivethisnewsletterinyourinb

WSS

Listen: Who gets the credit for GLP

Shingles, which affected Dianne Feinstein, is on the rise

Primary care physicians play key roles in Alzheimer's management

Food as medicine: Medically tailored meals may get standardized

FDA advisers vote against ALS treatment from BrainStorm

Would Medicare drug price negotiations stall in a shutdown?

explore

hotspot

leisure time

How one medical school became remarkably diverse

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Malaria cases in Florida and Texas: Here’s what you need to know

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Wildfire smoke exposes gaps in outdoor worker protections

Medicare drug price negotiation program allowed for now

Anesthesiologist group: stop taking Ozempic before surgery

FDA's naming rule on biosimilars has undermined competition

Drug repurposing or repositioning? The language matters

Study says nonprofit hospitals fall short in charity care spending

hotspot

Roche subsidiary Foundation Medicine opens new headquarters

There's no autism epidemic. It's an autism diagnosis epidemic

Why the world’s most expensive drug might be worth the price

Merck drug for rare lung condition set for approval in U.S.

Decaf coffee targeted by food safety group under obscure FDA rule

Readout Newsletter: Merck, Vertex, and Viking updates

leisure time

Wikipedia

hotspot

explore